Abstract
Rheumatoid arthritis (RA) is characterized by synovial inflammation mediated by T-cells, monocytes and macrophages. The homing of these cells to the inflamed synovium is regulated by chemokine-receptors and their ligands. A 32-basepair deletion (Δ32) in the gene encoding CCR5, a chemokine-receptor, results in a non-functional receptor. A negative association between CCR5-Δ32 and RA has been described, although other studies found no associations. Furthermore, the observation that individuals homozygous for CCR5-Δ32 develop RA has raised questions about the role of CCR5-Δ32. This meta-analysis of all published case–control association studies confirms the negative association between CCR5-Δ32 and RA (Odds Ratio=0.65; 95% confidence intervals=0.55–0.77; P<0.0001), suggesting that CCR5-Δ32 is protective against the development of RA. CCR5 blockade in animal models of RA results in amelioration of arthritis, suggesting that CCR5 blockade could also modify disease in patients with RA.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 digital issues and online access to articles
$119.00 per year
only $19.83 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Jawaheer D, Gregersen PK . The search for rheumatoid arthritis susceptibility genes: a call for global collaboration. Arthritis Rheum 2002; 46: 582–584.
Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN . Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 2003; 33: 177–182.
Loetscher P, Uguccioni M, Bordoli L, Baggiolini M, Moser B, Chizzolini C et al. CCR5 is characteristic of Th1 lymphocytes. Nature 1998; 391: 344–345.
Qin S, Rottman JB, Myers P, Kassam N, Weinblatt M, Loetscher M et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest 1998; 101: 746–754.
Suzuki N, Nakajima A, Yoshino S, Matsushima K, Yagita H, Okumura K . Selective accumulation of CCR5+ T lymphocytes into inflamed joints of rheumatoid arthritis. Int Immunol 1999; 11: 553–559.
Ruth JH, Rottman JB, Katschke Jr KJ, Qin S, Wu L, LaRosa G et al. Selective lymphocyte chemokine receptor expression in the rheumatoid joint. Arthritis Rheum 2001; 44: 2750–2760.
Katschke Jr KJ, Rottman JB, Ruth JH, Qin S, Wu L, LaRosa G et al. Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis. Arthritis Rheum 2001; 44: 1022–1032.
Robinson E, Keystone EC, Schall TJ, Gillett N, Fish EN . Chemokine expression in rheumatoid arthritis (RA): evidence of RANTES and macrophage inflammatory protein (MIP)-1 beta production by synovial T cells. Clin Exp Immunol 1995; 101: 398–407.
Koch AE, Kunkel SL, Harlow LA, Mazarakis DD, Haines GK, Burdick MD et al. Macrophage inflammatory protein-1 alpha. A novel chemotactic cytokine for macrophages in rheumatoid arthritis. J Clin Invest 1994; 93: 921–928.
Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuk R et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996; 86: 367–377.
Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, Farber CM et al. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996; 382: 722–725.
Garred P, Madsen HO, Petersen J, Marquart H, Hansen TM, Freiesleben Sorensen S et al. CC chemokine receptor 5 polymorphism in rheumatoid arthritis. J Rheumatol 1998; 25: 1462–1465.
Gomez-Reino JJ, Pablos JL, Carreira PE, Santiago B, Serrano L, Vicario JL et al. Association of rheumatoid arthritis with a functional chemokine receptor, CCR5. Arthritis Rheum 1999; 42: 989–992.
Pokorny V, McQueen F, Yeoman S, Merriman M, Merriman A, Harrison A et al. Evidence for negative association of the chemokine receptor CCR5 d32 polymorphism with rheumatoid arthritis. Ann Rheum Dis 2005; 64: 487–490.
Zapico I, Coto E, Rodriguez A, Alvarez C, Torre JC, Alvarez V . CCR5 (chemokine receptor-5) DNA-polymorphism influences the severity of rheumatoid arthritis. Genes Immun 2000; 1: 288–289.
Cooke SP, Forrest G, Venables PJ, Hajeer A . The delta32 deletion of CCR5 receptor in rheumatoid arthritis. Arthritis Rheum 1998; 41: 1135–1136.
John S, Smith S, Morrison JF, Symmons D, Worthington J, Silman A et al. Genetic variation in CCR5 does not predict clinical outcome in inflammatory arthritis. Arthritis Rheum 2003; 48: 3615–3616.
Venables PJ, Hajeer A . Delta32CCR5 and rheumatoid arthritis: comment on the article by Gomez-Reino et al. Arthritis Rheum 1999; 42: 2732–2733.
Mack M, Bruhl H, Gruber R, Jaeger C, Cihak J, Eiter V et al. Predominance of mononuclear cells expressing the chemokine receptor CCR5 in synovial effusions of patients with different forms of arthritis. Arthritis Rheum 1999; 42: 981–988.
Zuniga JA, Villarreal-Garza C, Flores E, Barquera R, Perez-Hernandez N, Montes de Oca JV et al. Biological relevance of the polymorphism in the CCR5 gene in refractory and non-refractory rheumatoid arthritis in Mexicans. Clin Exp Rheumatol 2003; 21: 351–354.
Bakhiet M, Tjernlund A, Mousa A, Gad A, Stromblad S, Kuziel WA et al. RANTES promotes growth and survival of human first-trimester forebrain astrocytes. Nat Cell Biol 2001; 3: 150–157.
Gonzalez E, Bamshad M, Sato N, Mummidi S, Dhanda R, Catano G et al. Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes. Proc Natl Acad Sci USA 1999; 96: 12004–12009.
Bamshad MJ, Mummidi S, Gonzalez E, Ahuja SS, Dunn DM, Watkins WS et al. A strong signature of balancing selection in the 5' cis-regulatory region of CCR5. Proc Natl Acad Sci USA 2002; 99: 10539–10544.
Mummidi S, Bamshad M, Ahuja SS, Gonzalez E, Feuillet PM, Begum K et al. Evolution of human and non-human primate CC chemokine receptor 5 gene and mRNA. Potential roles for haplotype and mRNA diversity, differential haplotype-specific transcriptional activity, and altered transcription factor binding to polymorphic nucleotides in the pathogenesis of HIV-1 and simian immunodeficiency virus. J Biol Chem 2000; 275: 18946–18961.
Little J, Bradley L, Bray MS, Clyne M, Dorman J, Ellsworth DL et al. Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations. Am J Epidemiol 2002; 156: 300–310.
Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR . Publication bias in clinical research. Lancet 1991; 337: 867–872.
Plater-Zyberk C, Hoogewerf AJ, Proudfoot AE, Power CA, Wells TN . Effect of a CC chemokine receptor antagonist on collagen induced arthritis in DBA/1 mice. Immunol Lett 1997; 57: 117–120.
Yang YF, Mukai T, Gao P, Yamaguchi N, Ono S, Iwaki H et al. A non-peptide CCR5 antagonist inhibits collagen-induced arthritis by modulating T cell migration without affecting anti-collagen T cell responses. Eur J Immunol 2002; 32: 2124–2132.
Acknowledgements
This work was supported by grants from The National Institute of Arthritis and Musculoskeletal and Skin Diseases (K23 AR50177), The National Center for Research Resources (M01-RR00064), The Val A Browning Charitable Foundation, and the Children's Health Research Center, Salt Lake City, UT. We would like to acknowledge Lynn Jorde PhD, Department of Human Genetics for critical review of the manuscript and suggestions for analysis.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Prahalad, S. Negative association between the chemokine receptor CCR5-Δ32 polymorphism and rheumatoid arthritis: a meta-analysis. Genes Immun 7, 264–268 (2006). https://doi.org/10.1038/sj.gene.6364298
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gene.6364298
Keywords
This article is cited by
-
Heme oxygenase-1 deficiency promotes severity of sepsis in a non-surgical preterm mouse model
Pediatric Research (2018)
-
Inflammatory Cell Migration in Rheumatoid Arthritis: A Comprehensive Review
Clinical Reviews in Allergy & Immunology (2016)
-
Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework
Nature Reviews Drug Discovery (2014)
-
Chemokine receptor 5 Δ32 polymorphism and systemic lupus erythematosus, vasculitis, and primary Sjogren’s syndrome
Zeitschrift für Rheumatologie (2014)
-
Maraviroc, a chemokine receptor-5 antagonist, fails to demonstrate efficacy in the treatment of patients with rheumatoid arthritis in a randomized, double-blind placebo-controlled trial
Arthritis Research & Therapy (2012)